Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism EBOV glycoprotein inhibitors(EBOV glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemorrhagic Fever, Ebola | Preclinical | US | 01 Nov 2018 | |
Hemorrhagic Fever, Ebola | Preclinical | US | 01 Nov 2018 | |
Hemorrhagic Fever, Ebola | Preclinical | US | 01 Nov 2018 |